NCT00061529 A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE3
NCT00061516 Safety and Efficacy Study of BETAXON 0.5% and AZOPT 1.0% in Pediatric Patients With Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE3
NCT00061503 Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE4
NCT00051194 A 6-week Safety & Efficacy Study of Combination Intraocular Pressure-lowering Therapy in Patients With Open-angle Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE2
NCT00051181 A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma Status COMPLETED Phase PHASE3
NCT00051155 A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT) Status COMPLETED Phase PHASE3
NCT00051142 A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT) Status COMPLETED Phase PHASE3
NCT00047606 Phase 4 Study Comparing IOP Lowering in OAG or OH in Caucasian or Japanese Subjects C-02-32 Status TERMINATED Phase PHASE4
NCT00047593 Phase 3 Study Comparing IOP Lowering in OAG or OH in Japanese Subjects C-01-98 Status COMPLETED Phase PHASE3
NCT00047541 Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-70 Status COMPLETED Phase PHASE3
NCT00047528 Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-02-41 Status COMPLETED Phase PHASE3
NCT00047515 Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-69 Status COMPLETED Phase PHASE3
NCT00001161 Abnormalities of the Eye's Anterior Chamber, Iris, Cornea and Lens Status COMPLETED Phase N/A